|6.00||+0.21 / +3.63%|
As of 3:59pm ET
|6.00||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 15.00, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +150.00% increase from the last price of 6.00.
The current consensus among 7 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.